Biaxin Could Benefit From Flu Vaccine Shortage Ahead Of Generic Competition
This article was originally published in The Pink Sheet Daily
Executive Summary
Abbott cautions that it is too early in the flu season to accurately predict the potential sales impact on the antibiotic brand, which is expected to face generic competition in May 2005. The company’s fourth quarter forecast assumes a conservative impact from the flu vaccine shortage.